Wang CZ - Search Results

1

Pharmacological and behavioral analysis of the effects of some bivalent ligand-based monoamine reuptake inhibitors.

Tamiz AP, Bandyopadhyay BC, Zhang J, Flippen-Anderson JL, Zhang M, Wang CZ, Johnson KM, Tella S, Kozikowski AP. Tamiz AP, et al. Among authors: wang cz. J Med Chem. 2001 May 10;44(10):1615-22. doi: 10.1021/jm000552s. J Med Chem. 2001. PMID: 11334571

2

Discovery of hepatitis B virus capsid assembly inhibitors leading to a heteroaryldihydropyrimidine based clinical candidate (GLS4).

Ren Q, Liu X, Luo Z, Li J, Wang C, Goldmann S, Zhang J, Zhang Y. Ren Q, et al. Bioorg Med Chem. 2017 Feb 1;25(3):1042-1056. doi: 10.1016/j.bmc.2016.12.017. Epub 2016 Dec 19. Bioorg Med Chem. 2017. PMID: 28082068

3

Design, synthesis, biological evaluation and docking study of 4-isochromanone hybrids bearing N-benzyl pyridinium moiety as dual binding site acetylcholinesterase inhibitors.

Wang C, Wu Z, Cai H, Xu S, Liu J, Jiang J, Yao H, Wu X, Xu J. Wang C, et al. Bioorg Med Chem Lett. 2015 Nov 15;25(22):5212-6. doi: 10.1016/j.bmcl.2015.09.063. Epub 2015 Sep 28. Bioorg Med Chem Lett. 2015. PMID: 26454504

4

Design, synthesis and biological evaluation of isochroman-4-one hybrids bearing piperazine moiety as antihypertensive agent candidates.

Xie S, Li X, Yu H, Zhang P, Wang J, Wang C, Xu S, Wu Z, Liu J, Zhu Z, Xu J. Xie S, et al. Bioorg Med Chem. 2019 Jul 1;27(13):2764-2770. doi: 10.1016/j.bmc.2019.05.004. Epub 2019 May 6. Bioorg Med Chem. 2019. PMID: 31078380

5

Design, synthesis and biological evaluation of hydrogen sulfide-releasing isochroman-4-one derivatives as new antihypertensive agent candidates.

Wu H, Li X, He C, Liu Y, Wang C, Yang X, Ma F, Liu J, Xu J. Wu H, et al. Bioorg Med Chem. 2022 Jun 15;64:116776. doi: 10.1016/j.bmc.2022.116776. Epub 2022 Apr 25. Bioorg Med Chem. 2022. PMID: 35483137

6

First total synthesis of antihypertensive natural products S-(+)-XJP and R-(-)-XJP.

Wang C, Wei G, Yang X, Yao H, Jiang J, Liu J, Shen M, Wu X, Xu J. Wang C, et al. Org Biomol Chem. 2014 Oct 7;12(37):7338-44. doi: 10.1039/c4ob01470g. Org Biomol Chem. 2014. PMID: 25116266

7

Manipulating ambient pressure superconductivity in metal borocarbides through hole doping.

Tian Q, Zhang W, Xia W, Liu H, Wang CZ. Tian Q, et al. Among authors: wang cz. J Phys Condens Matter. 2024 Dec 18. doi: 10.1088/1361-648X/ada105. Online ahead of print. J Phys Condens Matter. 2024. PMID: 39693741

8

Theoretical Exploration of the Synergistic Effect of Phosphate and Amidoxime for Uranium Recovery from Seawater.

Huang YC, Wang CZ, Wu QY, Lan JH, Nie CM, Chen SS, Song Y, Li H, Shi WQ. Huang YC, et al. Among authors: wang cz. Inorg Chem. 2024 Dec 16. doi: 10.1021/acs.inorgchem.4c03912. Online ahead of print. Inorg Chem. 2024. PMID: 39680860

9

Screening and validation of downstream target genes of SLC25A21 based on bioinformatics.

Chen Y, Wen X, Yuan FY, Peng CL, Wang CZ, Zhang J, Meng PP. Chen Y, et al. Among authors: wang cz. Yi Chuan. 2024 Dec;46(12):1055-1065. doi: 10.16288/j.yczz.24-230. Yi Chuan. 2024. PMID: 39658960

10

De-escalated neoadjuvant weekly nab-paclitaxel with trastuzumab and pertuzumab versus docetaxel, carboplatin, trastuzumab, and pertuzumab in patients with HER2-positive early breast cancer (HELEN-006): a multicentre, randomised, phase 3 trial.

Chen XC, Jiao DC, Qiao JH, Wang CZ, Sun XF, Lu ZD, Li LF, Zhang CJ, Yan M, Wei Y, Chen B, Feng YQ, Deng M, Ma MD, Plichta JK, He YW, Liu ZZ. Chen XC, et al. Among authors: wang cz. Lancet Oncol. 2025 Jan;26(1):27-36. doi: 10.1016/S1470-2045(24)00581-3. Epub 2024 Nov 26. Lancet Oncol. 2025. PMID: 39612919 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,052 results

Search Page

Filters